Skip to main content
Journal of Dental Research logoLink to Journal of Dental Research
. 2025 Oct 16;105(4):495–504. doi: 10.1177/00220345251366279

Mir-27 Promotes Periodontal Regeneration via Osteogenesis/Angiogenesis

Y Ding 1,2, J Luan 1,3, HS Malmstrom 4, X Luan 1,2, TGH Diekwisch 1,2,5,✉
PMCID: PMC13547813  PMID: 41102998

Abstract

The interplay between osteogenesis and angiogenesis is an important prerequisite for successful bone regeneration as it provides capillary supply to the initial bone lamellae involved in skeletogenesis. The Wnt signaling pathway is one of the key signaling pathways promoting both osteogenesis and angiogenesis. In the present study, we evaluated the regenerative potential of microRNA-27 (miR-27) by delivering miR-27 mimic via lipid nanoparticles (LNPs) to enhance periodontal tissue repair through the targeted modulation of Secreted Frizzled-Related Protein 1 (SFRP1). Our study demonstrated that inflammatory conditions inhibit the expression and function of miR-27 in a periodontitis model. miR-27 treatment significantly upregulated key modulators of periodontal regeneration, including osteogenic markers (ALP, RUNX2, and COL1) and angiogenic factors (CD31, CD34, and VEGF). This treatment also resulted in increased alkaline phosphatase activity and enhanced mineral deposition, alongside improved spheroid sprouting and tube formation in Matrigel cultures. LNPs were applied to optimize miR-27 delivery for efficient transfection. In vivo implantation revealed that miR-27 accelerated extracellular matrix remodeling in subcutaneous implants, induced a 6-fold increase in neovascularization, and significantly enhanced periodontal tissue formation and bone regeneration, as evidenced by a 43.9% reduction in the distance between the alveolar bone ridge and the cementoenamel junction. Mechanistically, miR-27 promoted osteogenic and angiogenic responses by suppressing SFRP1, a known Wnt signaling inhibitor and validated target of miR-27, thereby activating the Wnt pathway. Together, these studies demonstrate that miR-27 mimic functioned as a bioactive molecule promoting periodontal tissue regeneration through angiogenesis coinciding with osteogenesis. Our study also suggests that the miR-27-LNPs/scaffold combination is an exciting novel agent for the treatment of periodontal disease.

Keywords: microRNA, periodontal disease, tissue regeneration, nanomaterials, tissue engineering, Wnt signaling pathway

Introduction

Regenerative therapies of chronic diseases are designed to boost innate repair processes and regenerative potential (Terzic and Nelson 2013). These technologies include gene therapy, stem cell therapy, and tissue engineering. Among the molecules essential for life, microRNAs (miRNAs) provide potent mediators in many different physiological processes, including bone development, remodeling, and regeneration as well as blood vessel formation (Luan et al. 2017; Luan et al. 2018; Saliminejad et al. 2019; Hensley and McAlinden 2021; Shang et al. 2023). miRNAs affect gene expression by simultaneously regulating the endogenous expression of multiple target gene networks rather than controlling individual genes (Gurtan and Sharp 2013). Previous studies have illustrated that miR-27, as an activator of the Wnt signaling pathway, regulates the osteogenic differentiation of mesenchymal stem cells (Wang and Xu 2010; Shenoy and Blelloch 2014).

Bone is a tissue characterized by a rich vascular network (Mercado-Pagán et al. 2015). To facilitate the formation of this osteogenic vascular network, the process of bone development is intricately linked with angiogenesis, as mineralization occurs in parallel with the formation of blood vessels (Marks and Odgren 2002). Initial condensations of bone precursors are subsequently infiltrated by small blood vessels from the surrounding tissues prior to the onset of ossification (Tian et al. 2018). As mineralization begins, the newly formed bone becomes associated with a significant level of vascularization, both internally and externally (Thompson et al. 1989). The vascular system plays a critical role in delivering oxygen, nutrients, soluble factors, and various cell types to the developing bone, thereby supporting osteogenesis and preserving the structural integrity of bone tissue.

Periodontitis is a chronic inflammatory disease that affects the supporting structures of the teeth, characterized by progressive destruction of the alveolar bone and periodontal ligament. Its pathogenesis is complex, involving interactions between the microbial biofilm and the host immune response, which leads to local tissue inflammation and bone resorption. Although the host immune response is inherently a defense mechanism against microbial infection in the oral cavity, in the context of chronic inflammation, this response results in tissue damage and alveolar bone loss (Van Dyke et al. 2020). Several miRNAs have been identified as closely associated with the regulation of osteogenic and inflammatory pathways in periodontitis, positioning them as potential therapeutic targets for intervention (Luan et al. 2017; Luan et al. 2018; Cuevas-González et al. 2021; Santonocito et al. 2021). Previous studies have demonstrated that the expression levels of miR-27 family members were altered in periodontal tissues from periodontitis patients (Wa Lee et al. 2011; Xie et al. 2011). Based on the involvement miR-27 family members in inflammation (Xie et al. 2014; Li et al. 2021) and osteogenic differentiation of mesenchymal stem cells (Ren et al. 2021; Tang et al. 2021), our study focuses primarily on miR-27 function in alveolar bone remodeling.

Our preliminary evidence suggested that miR-27 application results in a generous regeneration of periodontal tissues, including periodontal attachment, connective tissue, and alveolar bone. However, the regulatory mechanism by which miR-27 affects periodontal tissue regeneration remains incompletely understood. Based on previous studies indicating that miR-27 targets SFRP1 (Zhang et al. 2024) and activates the Wnt pathway, we hypothesized that miR-27 influences both periodontal angiogenesis and osteogenesis through this regulatory axis, thereby promoting dual roles in angiogenesis and osteogenesis. We have tested our hypothesis by demonstrating the effect of miR-27 on SFRP1 and Wnt and by validating their effects on osteogenesis and angiogenesis. We have further devised a materials strategy that uses lipid nanoparticles (LNPs) as carriers and provides nutrient supply for new bone through enhanced vascularization to clinically improve vertical bone augmentation in thin alveolar ridges.

Materials and Methods

LNP Preparation

LNPs were prepared by mixing an ethanolic lipid mixture with an acidic aqueous buffer containing miR-27, and their size and zeta potential were characterized using dynamic light scattering, while the morphology of the LNPs was assessed via transmission electron microscopy (TEM). To monitor the encapsulation and transfection efficiency of the miRNA, Cy-3–labeled (Life Technologies) miRNAs were used. The encapsulation efficiency of the miR-27-LNPs was determined using the Ribogreen assay (Invitrogen). In vitro transfection efficiency was evaluated by transfecting human periodontal ligament (hPDL) cells with Cy3-labeled miR-27-LNPs, and fluorescence intensity was measured as an indicator of transfection efficiency. miR-27-LNPs were used to coat collagen sponge (Advanced Biomatrix) scaffolds, and miR-27 release was monitored at multiple time points over a 10-d period. To assess the in vivo transfection efficiency, Cy3-labeled miR-27-LNPs–coated collagen scaffolds were subcutaneously implanted into mice, and fluorescence activity was monitored using the IVIS imaging system.

Animal Experiments

Periodontitis mouse model

Our periodontitis model used 10-wk-old male and female C57BL/6 mice (Charles River). Briefly, mice were anesthetized with a combination of xylazine (Akorn) and ketamine (Hikma). A 5-0 silk suture was placed around the left maxillary second molar following the protocol described by Zhou et al. (2016) and Ma et al. (2021). The suture placement was monitored 3 times per week to ensure it remained in position. After 4 wk, the sutures were removed. Inflammation in periodontal tissues was subsequently assessed through clinical evaluation and histochemical analysis. All animal experiments complied with the ARRIVE 2.0 guidelines.

Detailed methods are provided in the appendix, including gingival flap surgery and implantation, subcutaneous implantation in mice, micro–computed tomographic (micro-CT) analysis, histology, immunofluorescence staining, cell culture, quantitative real-time polymerase chain reaction (qRT-PCR), Western blot analysis, detailed procedures for LNP preparation, and the statistical analysis.

Results

Inflammatory Conditions Inhibited miR-27 Function and Expression in Periodontitis Models

Studies presented here were performed to characterize the effect of a singular miRNA on periodontal osteogenesis and angiogenesis and to determine the mechanism that facilitates miR-27 function. To determine the effects of miR-27 on periodontal tissues, we have used a periodontitis ligature animal model. In this model, hematoxylin and eosin (H&E) staining (Fig. 1B vs. 1A) revealed that periodontal alveolar bone loss resulted in tissue breakdown and infiltration with inflammatory cells in the periodontal tissues. To identify potential candidate miRNA involved in bone loss and tissue degradation, we performed miRNA profiling studies. These studies identified miR-27 as miRNA significantly downregulated in periodontal tissues of periodontitis mice (Fig. 1C, D). This result was validated by qRT-PCR analysis (Fig. 1D). To further confirm whether the expression of miR-27 was inhibited under inflammatory conditions, hPDL cells were challenged with inflammatory factors, including high glucose, interleukin-6 (IL-6), lipopolysaccharide (LPS), and tumor necrosis factor–α (TNF-α). These factors suppressed miR-27 expression (Fig. 1E). To examine whether miR-27 is involved in osteogenic differentiation of hPDL cells and mineralization, hPDL cells were subjected to osteoinduction, revealing that miR-27 expression was upregulated under osteogenesis conditions. In contrast, LPS treatment inhibited miR-27 expression (Fig. 1F). To determine whether miR-27 functions as a positive regulator of osteoblast differentiation, both miR-27 mimic and inhibitor were applied to hPDL cell culture. miR-27 mimic enhanced whereas miR-27 inhibitor suppressed alkaline phosphatase (ALP) activity and mineral nodule formation (Fig. 1G, H and Appendix Fig. 1A, B). Matching results were obtained in Bone marrow mesenchymal stem cells (BMSCs) (Appendix Fig. 1C, D). In addition, miR-27 mimic upregulated while miR-27 inhibitor downregulated the bone marker genes ALP, Collagen Type I (COL1), and Osteocalcin (OCN) (Fig. 1I). These data indicate that miR-27 plays a significant role in the osteogenic differentiation of periodontal progenitor cells and that this effect is inhibited under inflammatory conditions.

Figure 1.

The image presents a detailed study on the regulation of miR-27 in periodontal disease, showcasing its downregulation in the periodontal ligament of periodontitis mice and its involvement in modulating osteogenesis in human periodontal ligament cells (hPDL) cultured in vitro. The experiments are divided into in vivo and in vitro aspects, using a preclinical model of periodontitis and observing the effects of various conditions such as inflammatory signals and differentiation on miR-27 expression. The data indicates that periodontitis mice exhibit reduced miR-27 levels, which correlates with increased osteogenic gene expression in hPDL cells treated with miR-27 mimics. This suggests a potential therapeutic target for periodontal disease, where modulation of miR-27 levels could influence the progression of alveolar bone loss, as highlighted by the use of qRT-PCR, Western blotting, and Alizred staining.

miR-27 was downregulated in the periodontal ligament of periodontitis mice in vivo and regulated the osteogenesis of hPDL cells in vitro. A preclinical periodontitis mouse model was established using a ligature placement approach (A–D). In vivo experimental conditions were mimicked using an hPDL cell culture system (E–I). (A, B) Hematoxylin and eosin staining of the periodontal tissues from WT and periodontitis mice. Panels a and b illustrate the magnified views of the boxed regions. Note the inflammatory infiltration and alveolar bone loss in the periodontium of periodontitis animals (n = 6). (C) Heat map generated from the miRNA array analysis of WT and periodontitis mice, revealing deregulation of several miRNAs, including miR-27 (n = 3). (D) Downregulation of miR-27 expression in periodontitis tissues (Perio) when compared with control PDL tissue and as revealed using qRT-PCR (n = 6). (E) Effect of inflammatory conditions on miR-27 expression in cultured hPDL cells (n = 3). (F) The differentiation of hPDL cells was induced via osteogenic induction. Note the positive effect of osteogenesis on miR-27 expression and the inhibition following LPS treatment (n = 3). (G, H) ALP activity and Alizarin Red staining of hPDL cells after 7 and 21 d of osteogenic differentiation. The miR-27 mimic enhanced whereas miR-27 inhibitor suppressed ALP activity and mineral nodule formation (n = 3). (I) qRT-PCR analysis demonstrated significantly elevated levels of bone-related genes following treatment with the miR-27 mimic (n = 3). ab, alveolar bone; ALP, alkaline phosphatase; CEJ, cementoenamel junction; Con, control; de, dentin; ggv, gingiva; HG, high glucose; hPDL, human periodontal ligament; IL-6, interleukin-6; infl, inflammatory cells; Inh, inhibitor; LPS, lipopolysaccharide; miRNA, micro RNA; OST, osteogenic induction; pdl, periodontal ligament; Perio, periodontitis; qRT-PCR, quantitative real-time polymerase chain reaction; TNF-α, tumor necrosis factor–α; WT, wild type. The data are presented as the mean ± standard deviation. *P < 0.05.

Generation and Characterization of miR-27-LNPs

Based on our in vivo and in vitro studies, we hypothesized that miR-27 is a key mediator of alveolar bone homeostasis. To efficiently apply miR-27 to periodontal tissues, we used LNPs for site-specific delivery of our miR-27. LNPs were synthesized using microfluidic technology and yielded particles with an average diameter of 66 nm. The miR-27-LNPs exhibited a zeta potential of −7 ± 1 mV and a polydispersity index of 0.14, indicating favorable dispersibility (Fig. 2A). TEM (Fig. 2B) documented that the LNPs were uniformly spherical. When coated onto collagen sponges, the LNPs displayed a consistent distribution of spherical particles (Fig. 2C). The transfection efficiency of the LNPs was assessed using Cy3-labeled miR-27-LNPs (Fig. 2E), and fluorescence imaging confirmed successful transfection in most hPDL cells. An increase in fluorescence activity was observed with escalating doses when 5,000 hPDL cells per well were treated with varying concentrations of miR-27-LNPs (Fig. 2F). The in vivo evaluation of LNPs’ stability and local distribution in mice was performed following subcutaneous implantation of collagen scaffolds, demonstrating a dose-dependent fluorescence response, with the highest signal intensity observed at the maximum miR-27 dose, which was 5-fold higher than that in the control group (Fig. 2G). No significant miR-27 changes were detected in major organs, confirming the safety of localized delivery (Appendix Fig. 2A). Notably, the miR-27-LNPs–coated collagen scaffolds did not impair cell adhesion, as evidenced by DAPI and F-actin staining (Fig. 2H, I). Live/dead fluorescence staining of hPDL cells revealed a survival rate exceeding 99% on both the control and miR-27–coated scaffolds (Fig. 2J and Appendix Fig. 2B). The cumulative release profile of miR-27-LNPs from the collagen scaffold indicated an accelerated release during the initial phase, with more than 40% released within the first 2 d and a total of 82% released over a 10-d period (Fig. 2D).

Figure 2.

The image presents a study on the generation, characterization, and controlled release of miR-27-LNPs and their impact on the proliferation and spread of periodontal ligament cells (hPDL). It showcases the morphological and microscopic analysis, including the size, zeta potential, and polydispersity index of LNPs, and images of transmission and scanning electron microscopy. The study also includes data on cellular transfection, fluorescence intensities, and live/death analysis of hPDL cells, providing a comprehensive understanding of the LNPs' behavior in different cell environments.

Generation and characterization of miR-27-LNPs and collagen scaffolds. (A) Characteristics of LNPs including size, zeta potential, and PDI. (B) Transmission electron microscopy image of the miR-27-LNP. (C) Scanning electron microscopy images of a control collagen sponge and an miR-27-LNPs–coated collagen sponge. (D) Controlled release of miR-27-LNPs from miR-27-LNPs–coated collagen sponge (n = 3). (E) hPDL cells transfected with Cy3-labeled miR-27-LNP. Red dots illustrate transfection with miR-27-LNPs. (F) hPDL cells treated with fluorescently labeled miR-27-LNPs (n = 3). Note the dose-dependent transfection efficiency. (G) C57BL/6 mice treated with control and fluorescently labeled miR-27-LNPs–coated collagen sponges (n = 6). (H, I) DAPI and F-actin labeling of hPDL cells in control and miR-27-LNPs–coated collagen sponges (n = 3). (J) Live/death analysis of hPDL cells in miR-27-LNPs–coated and control collagen sponges (n = 3). The data are presented as the mean ± standard deviation. *P < 0.05. **P < 0.01. Con, control; hPDL, human periodontal ligament; LNP, lipid nanoparticle; NP, nanoparticle; PDI, polydispersity index.

miR-27 Promoted Osteogenesis and Angiogenesis In Vitro and In Vivo

hPDL cells were cultured on both control and miR-27-LNPs–coated collagen scaffolds at a density of 106 cells per scaffold in a 3-dimensional bioreactor for 14 d. H&E staining showed a significantly increased cell density and enhanced matrix formation in the miR-27–treated group compared with the control group (Fig. 3B vs. 3A and Appendix Fig. 2C). Masson’s trichrome staining confirmed the presence of newly formed matrix within the collagen sponges (Fig. 3C, D). In addition, the BrdU incorporation assay illustrated that 79% of the cells on the miR-27-LNPs–coated scaffolds were actively proliferating, compared with 36% on the control scaffolds (Fig. 3E–G).

Figure 3.

The image consists of various microscopic and graphical data related to a study on the effects of miR-27 on the proliferation and differentiation of human periodontal ligament (hPDL) cells, as well as its impact on osteogenesis and angiogenesis. The study utilizes control and miR-27-LNPs-coated collagen scaffolds, both in vitro and in vivo. The text describes the experimental design, methods, and results of the study, highlighting the differences in cell proliferation, differentiation, and gene/protein expression between the control group and the miR-27 group.

miR-27 enhanced hPDL proliferation and differentiation in vitro and promoted osteogenesis and angiogenesis in vivo. Control and miR-27-LNPs–coated collagen constructs were either seeded with hPDL cells and cultured in a 3-dimensional bioreactor (A–G) or subcutaneously implanted (H–Q). (A, B) H&E staining of control and miR-27-LNPs–coated collagen scaffolds. The cell count per area was increased in the miR-27-LNPs–coated collagen scaffold (n = 5). (C, D) Masson staining illustrating increased newly formed extracellular matrix in the miR-27-LNPs–coated scaffolds compared with controls (n = 5). (E, F, G) A comparative analysis of BrdU incorporation demonstrated a marked increase in the number of BrdU-positive cells (stained brown) within the miR-27-LNPs–coated collagen sponge (n = 5). (H, I) H&E staining of control and miR-27-LNPs–coated collagen sponges subcutaneously implanted for 4 wk (n = 6). (J, K) Alizarin Red staining of control, miR-27-LNPs–coated collagen sponge implants after 4 wk of implantation (n = 6). Red stain indicates calcium deposition. (L–N) Masson trichrome staining visualized the newly formed matrix and blood vessels in miR-27-LNPs–coated collagen sponges. (O, P, Q) Relative expression of osteogenic and angiogenesis-related genes and proteins in subcutaneously implanted control and miR-27-LNPs–coated collagen sponges (n = 6). Black arrows indicate newly formed matrix. Yellow arrows indicate blood vessels. The data are presented as the mean ± standard deviation. *P < 0.05. **P < 0.01. H&E, hematoxylin and eosin; hPDL, human periodontal ligament; LNP, lipid nanoparticle.

To investigate the regulatory function of miR-27 in osteogenesis and angiogenesis/vasculogenesis, collagen sponges were coated with control or miR-27-LNPs, followed by subcutaneous implantation. After 4 wk, miR-27 promoted mineralization and new blood vessel formation in subcutaneous implants. Alizarin Red staining demonstrated that an miR-27 mimic significantly enhanced calcium deposition and tissue mineralization (Fig. 3J, K). Furthermore, Masson staining demonstrated that miR-27 mimic treatment resulted in a 6-fold increase in vessel formation compared with controls (Fig. 3L–N). qRT-PCR and Western blot analyses revealed a significant upregulation of both osteogenic markers (ALP, RUNX2, and COL1) and angiogenesis-related markers (VEGF, CD31, and CD34) at both the mRNA and protein levels in the miR-27–treated group (Fig. 3O–Q), with CD31 expression further validated by immunofluorescence staining (Appendix Fig. 2D). These findings demonstrate that miR-27 promotes enhanced angiogenesis–osteogenesis.

miR-27 Promoted Both Angiogenesis and Osteogenesis through the Wnt Signaling Pathway

Previous studies have revealed that SFRP1, an inhibitor of the Wnt/β-catenin pathway, influences both osteogenesis (Gopinathan et al. 2019) and angiogenesis (Dufourcq et al. 2008) in vitro and in vivo. Using prediction tools including TargetScan, we identified SFRP1 as a potential target of miR-27. To determine whether miR-27 affects endogenous SFRP1 expression, we transfected hPDL cells with either miR-27 mimic or inhibitor. Our data revealed that overexpression of miR-27 led to a reduction in SFRP1 expression, whereas inhibition of miR-27 resulted in an increase in SFRP1 levels (Fig. 4A). These results suggest that miR-27 enhances Wnt signaling by targeting its inhibitor, SFRP1, thereby enhancing both alveolar bone regeneration and angiogenesis.

Figure 4.

This image presents data on the effects of MiR-27 on osteogenesis, angiogenesis, Wnt signaling, and β-catenin localization using various assays and microscopic imaging. It includes bar graphs and images showing the percentage changes in SFRP1 expression, Wnt signaling, β-catenin nuclear localization, and collagen signaling in the context of bone and tissue. The data is analyzed using statistical significance testing and is presented as mean ± standard deviation, with p-values indicated for statistical significance.

miR-27 affects osteogenesis and angiogenesis through Wnt signaling. (A) qRT-PCR analysis demonstrated that miR-27 mimic downregulated while miR-27 inhibitor substantially upregulated SFRP1 expression under normal conditions. (B, C) Wnt signaling luciferase response as revealed by the TCF/LEF Cignal Reporter Assay Kit. Under osteogenic induction (B), miR-27 mimic increased Wnt signaling by 25%, while under angiogenesis induction conditions (C), miR-27 mimic more than doubled the Wnt signal. (D, E) β-Catenin immunofluorescence in hPDL cells cultured under osteogenic induction (D) or under angiogenic induction (E). The miR-27 mimic enhanced β-catenin nuclear localization while the miR-27 inhibitor suppressed β-catenin nuclear localization. (F, G) Spheroid sprouting and capillary morphology of hPDL treated with miRNA mimic control and miR-27 mimic under angiogenic induction. Note the effect of the miR-27 on capillary tube formation and sprouting. (H) qRT-PCR analysis demonstrated that miR-27 overexpression upregulated CD34, PDGF, and VEGF expression. (I) Western blot analysis of illustrating the effect miR-27 on osteogenic and angiogenic protein expression. Relative gray-scale density for each protein. White arrows indicate nuclear localization of β-catenin. The data are presented as the mean ± standard deviation (n = 3). *P < 0.05. **P < 0.01. hPDL, human periodontal ligament; qRT-PCR, quantitative real-time polymerase chain reaction; PDGF, platelet-derived growth factor; VEGF, vascular endothelial growth factor.

To further investigate whether miR-27 regulates both osteogenesis and angiogenesis by modulating Wnt/β-Catenin signaling, we used the TCF/LEF luciferase reporter assay under osteogenic (Fig. 4B) and angiogenic (Fig. 4C) induction conditions. Our results demonstrated that miR-27 significantly enhanced Wnt pathway activity under both conditions. Furthermore, immunofluorescence staining for β-catenin revealed that miR-27 overexpression promoted β-catenin nuclear localization, whereas treatment with the miR-27 inhibitor suppressed this effect (Fig. 4D, E and Appendix Fig. 3A, B). Furthermore, miR-27 mimic alleviated the inhibitory effect of SFRP1 protein on Wnt signaling, while miR-27 inhibitor suppressed the Wnt activation induced by SFRP1 siRNA (Appendix Fig. 3C, D). In hPDL cells, overexpression of miR-27 using miR-27 mimic significantly upregulated CD34, PDGF, and VEGF expression, as confirmed by qRT-PCR analysis and Western blot (Fig. 4H, I). This upregulation was associated with enhanced spheroid sprouting and tube formation in Matrigel cultures (Fig. 4F, G), indicating that miR-27 has a positive effect on angiogenesis. Similar proangiogenic effects were observed in human umbilical vein endothelial cells as a positive control (Appendix Fig. 3E, F).

miR-27 Application Restored the Periodontitis-Induced Alveolar Bone Defect and Promoted New Blood Vessel Formation at Alveolar Socket Walls

Here we have documented the substantial effect of miR-27 on periodontal osteogenesis and angiogenesis. To determine whether miR-27 modulates periodontal tissue regeneration, control and miR-27-LNPs–coated scaffolds were implanted into alveolar bone defects in mice subjected to our periodontitis regimen for 6 wk. Micro-CT analysis demonstrated a dramatic gain in alveolar bone height following miR-27 treatment. Specifically, the distance between the alveolar bone edge and the cementoenamel junction was reduced by 43.9% in the miR-27–treated C57BL/6 mice compared with the non–miR-treated periodontitis controls (Fig. 5A, B and Appendix Fig. 4A). Furthermore, the bone volume to tissue volume ratio was elevated, along with an increase in the number and thickness of trabeculae, accompanied by a reduction in trabecular spacing (Fig. 5C–F). Histological examination with H&E staining of periodontal tissues from the periodontitis control and miR-27–treated mice revealed a reduction in junctional epithelium attachment length, which was replaced by connective tissue attachment and gingival fibers. Furthermore, the miR-27–treated group exhibited a solid cervical alveolar bone ridge compared with the periodontitis control group (Fig. 5G, H). Masson staining demonstrated new matrix deposition, new blood vessel formation, and substantial amounts of new alveolar bone (Fig. 5I, J). In addition, immunofluorescence staining for VEGF revealed a pronounced increase in expression of VEGF in the miR-27–treated group (Fig. 5K, L and Appendix Fig. 4G). Gene expression analysis confirmed that miR-27 treatment promoted osteogenesis by upregulating osteogenesis-related genes and angiogenesis markers while also enhancing anti-inflammatory responses and reducing inflammation (Appendix Fig. 4B–E). CD31 immunofluorescence staining further corroborated increased angiogenesis in the miR-27–treated group (Appendix Fig. 4H). These results indicate that miR-27 treatment promoted alveolar bone regeneration, restored alveolar bone loss, and enhanced angiogenesis in periodontitis mice.

Figure 5.

In the image, periodontal defects treated with miR-27 mimic were shown. 3D micro-CT images of periodontitis control and miR-27 mimic-treated maxillae were used to demonstrate the reduction of distance between the cementoenamel junction and the alveolar bone ridge. Additionally, alveolar microCT parameters, gingival tissues stained with Hematoxylin and Eosin (H&E) were used to showcase formation of long epithelial pockets in periodontitis control while the periodontal ligament attachment was reestablished in the treated mice. Masson staining was used to highlight the increased number of blood vessels in the treated group. Finally, VEGF immunofluorescence staining was utilized to demonstrate an increase in VEGF expression in the same group compared to the control group as suggested by the presence of the white arrows in the image.

In periodontal defects, miR-27-LNPs–coated collagen sponges rescued the alveolar bone defects and periodontal ligament attachment after 6 wk. (A, B) Comparison between 3-dimensional reconstructed micro-CT images of periodontitis control and miR-27 mimic–treated maxillae. Note that the distance between the cementoenamel junction and the alveolar bone ridge was significantly reduced. (C–F) Alveolar bone micro-CT parameters from the periodontitis control and miR-27 mimic–treated mice. (G, H) Hematoxylin and eosin staining of periodontal tissues from periodontitis control and miR-27 mimic–treated mice. Note the formation of long epithelial pockets in the periodontitis control while the periodontal ligament attachment was reestablished in miR-27 mimic–treated mice. (I, J) Masson staining of periodontal tissues from periodontitis control and miR-27 mimic–treated mice. Note the increased number of blood vessels in the miR-27–treated group. (K, L) VEGF immunofluorescence staining of periodontal tissues from periodontitis control and miR-27 mimic–treated mice revealed an increased expression of VEGF in the miR-27 mimic–treated group. VEGF-positive areas are indicated by white arrows. CT, computed tomography; de, dentin; infl, inflammatory cells; VEGF, vascular endothelial growth factor. The data are presented as mean ± standard deviation (n = 6). *P < 0.05.

Discussion

In the present study, we have thoroughly assessed the role of miR-27 in modulating osteogenesis/angiogenesis, particularly in the context of inflammatory conditions and during tissue engineering. For this purpose, we have made use of an innovative LNPs delivery system as a means for miRNA delivery, due to its ability to protect nucleic acids from degradation and to facilitate targeted delivery to specific tissues (Xu and Xia 2023; Wei et al. 2024). miR-27 was chosen as an ideal modulator of osteoinductive angiogenesis, where the interplay between osteogenesis and angiogenesis is critical for coordinated tissue regeneration such as the earliest events of new bone formation and the interplay between inflammation and osteogenesis. To test the effectiveness of this novel strategy for tissue regeneration under physiological and pathological conditions, we have relied on our well-established periodontal inflammation and regeneration model in mice (Ma et al. 2021).

Our preliminary data demonstrated that miR-27 was significantly upregulated during osteogenic differentiation of mesenchymal stem cells. However, miR-27 expression was downregulated under inflammatory conditions. Based on this finding, miR-27 emerged as a promising candidate for tissue engineering, particularly in the context of periodontal inflammation and bone regeneration. The downregulation of miR-27 observed in periodontitis mice, alongside its inhibition by key inflammatory mediators such as IL-6, LPS, and TNF-α, underscores its sensitivity to inflammatory conditions, which is a critical factor in the pathogenesis of periodontitis. These findings align with previous studies that have demonstrated the regulatory role of miRNAs in osteogenic differentiation and inflammation (Luan et al. 2017; Luan et al. 2018; Luan et al. 2022), highlighting miR-27’s dual function in modulating both processes. The significant upregulation of miR-27 during osteogenic differentiation, as shown in our in vitro experiments, further reinforces its potential as a therapeutic target and suggests that miR-27 actively promotes osteoblast differentiation, making it an ideal candidate for enhancing bone regeneration under inflammatory conditions, where traditional regenerative approaches may fall short due to the detrimental effects of inflammation on bone tissue.

In our study, we observed a dual role of miR-27 in promoting both osteogenesis and angiogenesis, highlighting its potential as a candidate for therapeutic interventions in periodontal tissue regeneration. The initial evidence for miR-27’s effectiveness emerged from our in vitro experiments, which demonstrated a significant increase in mineralized nodule formation, upregulation of RUNX2 signaling, and enhanced COL1 deposition in the extracellular matrix. In addition, miR-27’s proangiogenic effects were evident through the upregulation of key angiogenic factors such as VEGF, PDGF, and CD34, along with the formation of capillary-like structures and the promotion of spheroid sprouting. This is in line with prior research emphasizing the regulatory role of miRNAs in angiogenesis (Wang et al. 2018; Leone et al. 2019). The interplay between osteogenesis and angiogenesis is well established, with studies demonstrating that vascularization is crucial for bone formation (Kusumbe et al. 2014). Our data further confirm that miR-27 downregulates SFRP1, a well-known antagonist of the Wnt pathway, thereby activating Wnt signaling to promote both osteoblast differentiation (Gopinathan et al. 2019) and angiogenesis. Notably, under conditions that induce osteogenesis and angiogenesis, miR-27 enhanced Wnt pathway activity and promoted the nuclear localization of β-catenin. These findings underscore miR-27’s capacity to promote both bone formation and angiogenesis within the periodontal microenvironment, positioning miR-27 as a pivotal regulator of periodontal tissue regeneration.

One essential aspect of our engineering approach was the preparation of miR-27-LNPs to protect nucleic acids from degradation and facilitate the targeted delivery to specific tissues in this delivery system. Previous studies have demonstrated that LNP-mediated miRNA delivery significantly enhanced bone tissue repair under inflammatory conditions (Yang et al. 2024). In our study, the use of LNPs to deliver miR-27 was predicted to restore its expression levels in periodontal tissues, even under inflammatory conditions, and facilitated the repair of periodontitis-induced alveolar bone defects while promoting new blood vessel formation at the alveolar socket walls. This restoration was accompanied by significant improvements in bone formation and angiogenesis, both of which are crucial for successful bone regeneration. Angiogenesis, in particular, plays a vital role in providing essential nutrients and oxygen for regenerating tissues (Pardue et al. 2008; Nazarnezhad et al. 2022). The dual effect of enhanced osteogenesis and angiogenesis not only counteracted the inhibitory effects of inflammatory cytokines but also created a more favorable environment for tissue regeneration (Reddy et al. 2020).

Our subcutaneous implantation model provides an ideal approach to test the suitability of a tissue-engineering strategy in an environment mimicking in vivo biological interactions as faithful as possible (Ma et al. 2021). Using this approach, our data demonstrated the upregulation of both mineralization markers and angiogenesis markers (ALP, RUNX2, COL1, VEGF, CD31, and CD34), encouraging us to conduct in vivo studies in mice as a next step. This dual function offers a distinct advantage for developing biomaterials that not only support osteogenesis but also stimulate angiogenesis, an essential process for sustained tissue regeneration. It would be interesting to explore in future studies whether angiogenesis was directly coupled to osteogenesis, and this could be done by adding an angiogenesis inhibitor and test its effect on osteogenesis.

Author Contributions

Y. Ding, X. Luan, T.G.H. Diekwisch, contributed to conception, design, data acquisition, analysis, and interpretation, drafted and critically revised the manuscript; J. Luan, contributed to conception, design, data acquisition, drafted and critically revised the manuscript; H.S. Malmstrom, contributed to conception, data interpretation, drafted and critically revised the manuscript. All authors gave final approval and agree to be accountable for all aspects of the work.

Supplemental Material

sj-docx-1-jdr-10.1177_00220345251366279 – Supplemental material for Mir-27 Promotes Periodontal Regeneration via Osteogenesis/Angiogenesis

Supplemental material, sj-docx-1-jdr-10.1177_00220345251366279 for Mir-27 Promotes Periodontal Regeneration via Osteogenesis/Angiogenesis by Y. Ding, J. Luan, H.S. Malmstrom, X. Luan and T.G.H. Diekwisch in Journal of Dental Research

Footnotes

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Generous support by NIDCR grants R01 DE 27686 to XL and DE027930 to TGHD is gratefully acknowledged.

ORCID iD: T.G.H. Diekwisch Inline graphic https://orcid.org/0000-0003-3356-9677

A supplemental appendix to this article is available online.

References

  1. Cuevas-González MV, Suaste-Olmos F, García-Calderón AG, Tovar-Carrillo KL, Espinosa-Cristóbal LF, Nava-Martínez SD, Cuevas-González JC, Zambrano-Galván G, Saucedo-Acuña RA, Donohue-Cornejo A. 2021. Expression of microRNAs in periodontal disease: a systematic review. BioMed Res Int. 2021(1):2069410. doi: 10.1155/2021/2069410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dufourcq P, Couffinhal T, Ezan J, Barandon L, Daret D, Costet P, Duplàa C. 2008. Secreted frizzled-related protein-1 enhances mesenchymal stem cell function in angiogenesis and contributes to neovessel maturation. Stem Cells. 26(11):2991–3001. [DOI] [PubMed] [Google Scholar]
  3. Gopinathan G, Foyle D, Luan X, Diekwisch TG. 2019. The Wnt antagonist SFRP1: a key regulator of periodontal mineral homeostasis. Stem Cells Dev. 28(15):1004–1014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gurtan AM, Sharp PA. 2013. The role of miRNAs in regulating gene expression networks. J Mol Biol. 425(19):3582–3600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hensley AP, McAlinden A. 2021. The role of microRNAs in bone development. Bone. 143:115760. doi: 10.1016/j.bone.2020.115760 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kusumbe AP, Ramasamy SK, Adams RH. 2014. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 507(7492):323–328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Leone P, Buonavoglia A, Fasano R, Solimando AG, De Re V, Cicco S, Vacca A, Racanelli V. 2019. Insights into the regulation of tumor angiogenesis by microRNAs. J Clin Med. 8(12):2030. doi: 10.3390/jcm8122030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Li L, Qi C, Liu Y, Shen Y, Zhao X, Qin H, Zhang Y, Yu T. 2021. MicroRNA mir-27b-3p regulate microglial inflammation response and cell apoptosis by inhibiting A20 (TNF-α-induced protein 3). Bioengineered. 12(2):9902–9913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Luan X, Zhou X, Fallah P, Pandya M, Lyu H, Foyle D, Burch D, Diekwisch TG. 2022. MicroRNAs: harbingers and shapers of periodontal inflammation. Semin Cell Dev Biol. 124:85–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Luan X, Zhou X, Naqvi A, Francis M, Foyle D, Nares S, Diekwisch TG. 2018. MicroRNAs and immunity in periodontal health and disease. Int J Oral Sci. 10(3):24. doi: 10.1038/s41368-018-0025-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Luan X, Zhou X, Trombetta-eSilva J, Francis M, Gaharwar A, Atsawasuwan P, Diekwisch T. 2017. MicroRNAs and periodontal homeostasis. J Dent Res. 96(5):491–500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ma W, Lyu H, Pandya M, Gopinathan G, Luan X, Diekwisch T. 2021. Successful application of a galanin-coated scaffold for periodontal regeneration. J Dent Res. 100(10):1144–1152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Marks SC, Jr, Odgren PR. 2002. Structure and development of the skeleton. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. 2nd ed. San Diego (CA): Academic Press. p. 3–15. [Google Scholar]
  14. Mercado-Pagán ÁE, Stahl AM, Shanjani Y, Yang Y. 2015. Vascularization in bone tissue engineering constructs. Ann Biomed Eng. 43(3):718–729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nazarnezhad S, Kargozar S, Hamblin MR. 2022. Skin wound healing: the critical role of angiogenesis. In: Kargozar S, Mozafari M, editors. Biomaterials for vasculogenesis and angiogenesis. Cambridge (MA): Elsevier. p. 439–463. [Google Scholar]
  16. Pardue EL, Ibrahim S, Ramamurthi A. 2008. Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering. Organogenesis. 4(4):203–214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Reddy LVK, Murugan D, Mullick M, Begum Moghal ET, Sen D. 2020. Recent approaches for angiogenesis in search of successful tissue engineering and regeneration. Curr Stem Cell Res Ther. 15(2):111–134. [DOI] [PubMed] [Google Scholar]
  18. Ren L-R, Yao R-B, Wang S-Y, Gong X-D, Xu J-T, Yang K-S. 2021. MiR-27a-3p promotes the osteogenic differentiation by activating CRY2/ERK1/2 axis. Mol Med. 27(1):43. doi: 10.1186/s10020-021-00303-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. 2019. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 234(5):5451–5465. [DOI] [PubMed] [Google Scholar]
  20. Santonocito S, Polizzi A, Palazzo G, Isola G. 2021. The emerging role of microRNA in periodontitis: pathophysiology, clinical potential and future molecular perspectives. Int J Mol Sci. 22(11):5456. doi: 10.3390/ijms22115456 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shang R, Lee S, Senavirathne G, Lai EC. 2023. MicroRNAs in action: biogenesis, function and regulation. Nat Rev Genet. 24(12):816–833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shenoy A, Blelloch RH. 2014. Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat Rev Mol Cell Biol. 15(9):565–576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tang J, Yu H, Wang Y, Duan G, Wang B, Li W, Zhu Z. 2021. MiR-27a promotes osteogenic differentiation in glucocorticoid-treated human bone marrow mesenchymal stem cells by targeting PI3K. J Mol Histol. 52(2):279–288. [DOI] [PubMed] [Google Scholar]
  24. Terzic A, Nelson TJ. 2013. Regenerative medicine primer. Mayo Clin Proc. 88(7):766–775. [DOI] [PubMed] [Google Scholar]
  25. Thompson T, Owens P, Wilson D. 1989. Intramembranous osteogenesis and angiogenesis in the chick embryo. J Anat. 166:55–65. [PMC free article] [PubMed] [Google Scholar]
  26. Tian T, Zhang T, Lin Y, Cai X. 2018. Vascularization in craniofacial bone tissue engineering. J Dent Res. 97(9):969–976. [DOI] [PubMed] [Google Scholar]
  27. Van Dyke TE, Bartold PM, Reynolds EC. 2020. The nexus between periodontal inflammation and dysbiosis. Front Immunol. 11:511. doi: 10.3389/fimmu.2020.00511 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wa Lee YH, Am Na HS, Jeong SY, Jeong SHE, Park HRY, Chung J. 2011. Comparison of inflammatory microRNA expression in healthy and periodontitis tissues. Biocell. 35(2):43–49. [PubMed] [Google Scholar]
  29. Wang T, Xu Z. 2010. MiR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun. 402(2):186–189. [DOI] [PubMed] [Google Scholar]
  30. Wang Y, Wang L, Chen C, Chu X. 2018. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications. Mol Cancer. 17(1):22. doi: 10.1186/s12943-018-0766-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wei P-S, Thota N, John G, Chang E, Lee S, Wang Y, Ma Z, Tsai Y-H, Mei K-C. 2024. Enhancing RNA-lipid nanoparticle delivery: organ-and cell-specificity and barcoding strategies. J Control Release. 375:366–388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Xie N, Cui H, Banerjee S, Tan Z, Salomao R, Fu M, Abraham E, Thannickal VJ, Liu G. 2014. MiR-27a regulates inflammatory response of macrophages by targeting IL-10. J Immunol. 193(1):327–334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Xie YF, Shu R, Jiang Sy, Liu Dl, Zhang Xl. 2011. Comparison of microRNA profiles of human periodontal diseased and healthy gingival tissues. Int J Oral Sci. 3(3):125–134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Xu X, Xia T. 2023. Recent advances in site-specific lipid nanoparticles for mRNA delivery. ACS Nanosci Au. 3(3):192–203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Yang J, Zhang T, Zhu X, He Z, Jiang X, Yu S. 2024. MiRNA-223-5p inhibits hypoxia-induced apoptosis of BMSCs and promotes repair in Legg-Calvé-Perthes disease rabbit model by targeting CHAC2 and activating the Wnt/β-catenin signaling pathway. PloS One. 20(1):e0315230. doi: 10.1371/journal.pone.0315230 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zhang DF, Jin XN, Ma X, Qiu YS, Ma W, Dai X, Zhang Z. 2024. Tumour necrosis factor α regulates the miR-27a-3p–Sfrp1 axis in a mouse model of osteoporosis. Exp Physiol. 109(7):1109–1123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Zhou X, Luan X, Chen Z, Francis M, Gopinathan G, Li W, Lu X, Li S, Wu C, Diekwisch T. 2016. MicroRNA-138 inhibits periodontal progenitor differentiation under inflammatory conditions. J Dent Res. 95(2):230–237. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

sj-docx-1-jdr-10.1177_00220345251366279 – Supplemental material for Mir-27 Promotes Periodontal Regeneration via Osteogenesis/Angiogenesis

Supplemental material, sj-docx-1-jdr-10.1177_00220345251366279 for Mir-27 Promotes Periodontal Regeneration via Osteogenesis/Angiogenesis by Y. Ding, J. Luan, H.S. Malmstrom, X. Luan and T.G.H. Diekwisch in Journal of Dental Research


Articles from Journal of Dental Research are provided here courtesy of International and American Associations for Dental Research

RESOURCES